Cognitive impairment, fatigue and depression in multiple sclerosis: Is there a difference between benign and

Hans Bogaardt1, Daniel Golan2, Marissa A Barrera3

  • 1School of Allied Health Science and Practice, University of Adelaide, Adelaide, Australia.

Abstract

Insights

Cognitive impairment, fatigue, and depression are common in benign multiple sclerosis (MS) despite low Expanded Disability Status Scale (EDSS) scores. Current definitions of benign MS may not fully capture the patient experience.

Area of Science:

  • Neurology
  • Neuroscience
  • Clinical Medicine

Background:

  • Multiple Sclerosis (MS) is a chronic CNS disease impacting disability, often measured by the Expanded Disability Status Scale (EDSS).
  • Benign MS (BMS) is defined by low EDSS scores (≤3) and long disease duration (≥10 years), but its existence and definition are debated.
  • The EDSS may not adequately assess cognitive function, fatigue, depression, or anxiety in people with MS (PwMS).

Purpose of the Study:

  • To investigate the prevalence of cognitive impairment, fatigue, and depression in individuals meeting the EDSS-based definition of benign MS (BMS).
  • To compare these outcomes in PwBMS with those in PwMS with non-benign MS (PwNBMS) and shorter disease duration.
  • To evaluate the adequacy of the current EDSS-based definition of BMS.

Main Methods:

  • 141 individuals with BMS (PwBMS) and 158 with non-benign MS (PwNBMS) (≥10 years duration, EDSS >3) were assessed.
  • Cognitive function was evaluated using the NeuroTrax® computerized test battery across seven domains.
  • Fatigue was measured by the Fatigue Severity Scale (FSS), and depression by the Beck Depression Inventory (BDI).

Main Results:

  • Cognitive impairment affected 38% of PwBMS compared to 66% of PwNBMS (p<0.001).
  • Information processing (32%) and verbal function (18%) were the most and least affected cognitive domains in PwBMS, respectively.
  • Fatigue (78%) and depression (55%) were highly prevalent in PwBMS, with no significant difference compared to PwNBMS.

Conclusions:

  • Cognitive impairment, fatigue, and depression are prevalent in individuals classified with benign MS based on EDSS.
  • The current EDSS-based definition of benign MS may be insufficient to capture the full spectrum of disability.
  • A revised definition of benign MS should incorporate cognitive, fatigue, and mood assessments for a more accurate representation.

Related Concept Videos

Negative and Cognitive Symptoms of Schizophrenia01:30

Negative and Cognitive Symptoms of Schizophrenia

Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
104
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
183
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
304
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
558
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
172
Long-term Depression01:03

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
2.6K